摘要
近年来非酒精性脂肪性肝病(non alcoholic fatty liver disease,NAFLD)的发病率逐年升高,已成为健康人群肝酶异常的首要原因,由于其发病机制属于多因素的复杂过程,目前还无明确的治疗共识。许多相关研究显示,NAFLD的发病、诊治及预后等均与2型糖尿病(type 2 diabetes mellitus,T2DM)关系密切,因此T2DM的治疗手段包括生活方式、药物、减重手术等逐渐应用于NAFLD,文章拟对上述方法在NAFLD的治疗应用作简单概述。
Non-alcoholic fatty liver disease(NAFLD),the incidence of which grows rapidly,has become the main cause of abnormal liver enzymes in healthy individuals.By now,no clear consensus has been reached on the treatment due to the multi-factorial pathogenesis of NAFLD.It has been indicated by a lot of studies that there is a close association between the pathogenesis,treatment and prognosis of non-alcoholic fatty liver disease and type 2 diabetes.So some measures of type 2 diabetes,including lifestyle intervention,medication and bariatric surgery,have been gradually used for NAFLD patients.This article introduces and summarizes the above-mentioned treatment for nonalcoholic fatty liver disease.
作者
敖娜
都健
AO Na;DU Jian(Department of Endocrinology and Metabolism.The Fourth Affiliated Hospital,China Medical University,Shenyang 110032,China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2019年第3期231-234,共4页
Chinese Journal of Practical Internal Medicine
关键词
非酒精性脂肪性肝病
2型糖尿病
生活方式
降糖药物
减重手术
non-alcoholic fatty liver disease
type 2 diabetes
lifestyle intervention
antidiabetics
bariatric surgery
